Patient basic information Patient: Ms Nadia (Nadia Walker) Nationality: Ethiopia Disease Diagnosis: Leukemia Diagnostic Hospital: H0ZO treatment program: Immunotherapy + Targeted Treatment Accommodation days: 41 days Treatment cost: about 776512 yuan Treatment effect: Complete alleviation Description: Ms Nadia is from Ethiopia and was diagnosed with leukemia locally. Upon arrival, the International Medical Service Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process. During the treatment process, the International Medical Service Team employed a comprehensive set of immunotherapies + targeted therapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs.
After 41 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. The patient's treatment effects were finally completely alleviated. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to track recovery through a remote follow-up system.
The patient commented: 'The level of expertise of Chinese doctors and the condition of equipment in Chinese hospitals impressed us, with a well-equipped line arranged from the ground to the hospital. 'Mrs. Liu Nadia, experts have criticized the case as a typical case of cross-border suspected seriousness clinical cases.
Liu4 is a multidisciplinary collaborative mechanism that develops immunotherapy+focused treatments for leukemia, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics, and a shorthand for the regulation of the international delivery of medical services. (Figure from Liu5 official news reports and medical scenarios)












